Mehta, D., Raison, C. L., Woolwine, B. J., Haroon, E., Binder, E. B., Miller, A. H., & Felger, J. C. (2013). Transcriptional Signatures Related to Glucose and Lipid Metabolism Predict Treatment Response to the Tumor Necrosis Factor Antagonist Infliximab in Patients with Treatment-Resistant Depression.
Chicago Style citaatMehta, Divya, Charles L. Raison, Bobbi J. Woolwine, Ebrahim Haroon, Elisabeth B. Binder, Andrew H. Miller, en Jennifer C. Felger. Transcriptional Signatures Related to Glucose and Lipid Metabolism Predict Treatment Response to the Tumor Necrosis Factor Antagonist Infliximab in Patients With Treatment-Resistant Depression. 2013.
MLA citatieMehta, Divya, et al. Transcriptional Signatures Related to Glucose and Lipid Metabolism Predict Treatment Response to the Tumor Necrosis Factor Antagonist Infliximab in Patients With Treatment-Resistant Depression. 2013.